Results 201 to 210 of about 31,226 (229)

Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data

Ophthalmology, 2020
Glenn Jaffe, David Sarraf, K Bailey Freund   +2 more
exaly  

Intravitreous injection of AAV2-sFLT01 in patients with advanced neovascular age-related macular degeneration: a phase 1, open-label trial

Lancet, The, 2017
Abraham Scaria, Peter A Campochiaro
exaly  

HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration

Ophthalmology, 2020
Yuichiro Ogura, Ursula M Schmidt-Erfurth, David Brown   +2 more
exaly  

Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration

New England Journal of Medicine, 2011
Maureen G Maguire, Gui-shuang Ying, Juan E Grunwald   +2 more
exaly  

Age-related macular degeneration

Lancet, The, 2018
Paul Mitchell, Gerald Liew, Bamini Gopinath   +2 more
exaly  

NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

2019
openaire   +1 more source

Neovascular Age-Related Macular Degeneration

Michael D. Lewen, Andre Witkin
openaire   +1 more source

Age-related macular degeneration

Lancet, The, 2008
Chi-Chao Chan, Emily Chew
exaly  

Non-neovascular Age-related Macular Degeneration

2015
Jay Duker, James Fujimoto, Nadia Waheed, Talisa Carlo, Eric Moult, WooJhon Choi   +5 more
openaire   +1 more source

Non-neovascular age-related macular degeneration

2010
Stephan Michels, Gerhard Garhöfer, Malaika M. Kurz-Levin   +2 more
openaire   +1 more source